Experimental studies have shown that: (i) inhibition of JNK in the liver leads to a beneficial effect on insulin resistance and glucose tolerance 49; (ii) JNK is abnormally activated in obesity 28 and (iii) its absence leads to a decrease in adiposity and to an improvement in insulin sensitivity 50. This evidence concerns the gene MAPK8 and obesity due to melanocortin 4 receptor deficiency.